List of substances in Schedule I Verdrag inzake psychotrope stoffen
International non-proprietary name (INN) | Other non-proprietary or trivial names | Chemical name
25B-NBOMe, 2C-B-NBOMe | 2-(4-Bromo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
Brolamfetamine | DOB | (±)-4-Bromo-2,5-dimethoxy-α-methylphenethylamine
25C-NBOMe, 2C-C-NBOMe | 2-(4-Chloro-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
Cathinone | | (-)-(S)-2-Aminopropiophenone
DET | 3-[2-(Diethylamino)ethyl]indole
DMA | (±)-2,5-Dimethoxy-α-methylphenethylamine
DMHP | 3-(1,2-Dimethylheptyl)-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol
DMT | 3-[2-(Dimethylamino)ethyl]indole
DOC | 1-(4-Chloro-2,5-dimethoxyphenyl)propan-2-amine
DOET | (±)-4-Ethyl-2,5-dimethoxy-α-methylphenethylamine
Eticyclidine | PCE | N-Ethyl-1-phenylcyclohexylamine
Etryptamine | | 3-(2-Aminobutyl)indole
N-Hydroxy MDA | (±)-N-[α-Methyl-3,4-(methylenedioxy)phenethyl]hydroxylamine
25I-NBOMe, 2C-I-NBOMe | 2-(4-Iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine
(+)-Lysergide | LSD, LSD-25 | 9,10-Didehydro-N,N-diethyl-6-methylergoline-8β-carboxamide
MDE, N-Ethyl MDA | (±)-N-Ethyl-α-methyl-3,4-(methylenedioxy)phenethylamine
MDMA | (±)-N,α-Dimethyl-3,4-(methylenedioxy)phenethylamine
Mescaline | 3,4,5-Trimethoxyphenethylamine
Methcathinone | 2-(Methylamino)-1-phenylpropan-1-one
4-Methylaminorex | (±)-cis-2-Amino-4-methyl-5-phenyl-2-oxazoline
MMDA | 5-Methoxy-α-methyl-3,4-(methylenedioxy)phenylethylamine
4-MTA | α-Methyl-4-methylthiophenethylamine
Parahexyl | 3-Hexyl-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol
para-Methoxymethylamphetamine, PMMA | 1-(4-Methoxyphenyl)-N-methylpropan-2-amine
PMA | p-Methoxy-α-methylphenylethylamine
Psilocine, psilotsin | 3-[2-(Dimethylamino)ethyl]indol-4-ol
Psilocybine | | 3-[2-(Dimethylamino)ethyl]indol-4-yl hydrogen phosphate
Rolicyclidine | PHP, PCPY | 1-(1-Phenylcyclohexyl)pyrrolidine
STP, DOM | 2,5-Dimethoxy-α,4-dimethylphenethylamine
Tenamfetamine | MDA | α-Methyl-3,4-(methylenedioxy)phenethylamine
Tenocyclidine | TCP | 1-[1-(2-Thienyl)cyclohexyl]piperidine
Tetrahydrocannabinol, the following isomers and their stereochemical variants:
7,8,9,10-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol 8,9,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
6a,9,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
6a,7,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
6a,7,8,9-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
6a,7,8,9,10,10a-Hexahydro-6,6-dimethyl-9-methylene-3-pentyl-6H-dibenzo[b,d]pyran-1-ol
TMA | (±)-3,4,5-Trimethoxy-α-methylphenethylamine
The salts of the substances listed in this Schedule whenever the existence of such salts is possible.
The stereoisomers, unless specifically excepted, of substances in this Schedule, whenever the existence of such stereoisomers is possible within the specific chemical designation.
- Regeling
- Verdrag inzake psychotrope stoffen
- Soort
- Verdrag
- Geldend vanaf
- 06-12-2025
- BWB-id
- BWBV0003922
- Versie
- 2025-12-06_0